Skip to content

Opening book details…

About this Medicine article

Fenofibrate decreases plasma ceramide in type 2 diabetes patients: A novel marker of CVD? by Croyal, M.; Kaabia, Z.; León, L.; Ramin-Mangata, S.; Baty, T.; Fall, F.; Billon-Crossouard, S.; Aguesse, A.; Hollstein, T.; Sullivan, D.R.; Nobecourt, E.; Lambert, G.; Krempf, M. is a Medicine article available to read on EtoBox.

It is typically read by researchers, students, and practitioners in Medicine.

Author
Croyal, M.; Kaabia, Z.; León, L.; Ramin-Mangata, S.; Baty, T.; Fall, F.; Billon-Crossouard, S.; Aguesse, A.; Hollstein, T.; Sullivan, D.R.; Nobecourt, E.; Lambert, G.; Krempf, M.
Publisher
Masson Editeur; Elsevier ; Elsevier Masson; Elsevier BV (ISSN 1262-3636)
Published
2017
Language
EN
Field
Medicine (Health Sciences)

More by Croyal, M.; Kaabia, Z.; León, L.; Ramin-Mangata, S.; Baty, T.; Fall, F.; Billon-Crossouard, S.; Aguesse, A.; Hollstein, T.; Sullivan, D.R.; Nobecourt, E.; Lambert, G.; Krempf, M.

Browse all works by Croyal, M.; Kaabia, Z.; León, L.; Ramin-Mangata, S.; Baty, T.; Fall, F.; Billon-Crossouard, S.; Aguesse, A.; Hollstein, T.; Sullivan, D.R.; Nobecourt, E.; Lambert, G.; Krempf, M.